(Q35345642)
Statements
1 reference
Neoadjuvant dual HER2-targeted therapy with lapatinib and trastuzumab improves pathologic complete response in patients with early stage HER2-positive breast cancer: a meta-analysis of randomized prospective clinical trials (English)
1 reference
Mellissa Hicks
Erin R Macrae
Rachel Layman
Susan Friedman
Jenny Querry
Maryam Lustberg
Bhuvaneswari Ramaswamy
Ewa Mrozek
Charles Shapiro
2 March 2015
1 reference